Viewing Study NCT04300959


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-01-01 @ 8:27 PM
Study NCT ID: NCT04300959
Status: UNKNOWN
Last Update Posted: 2020-03-09
First Post: 2020-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer
Sponsor:
Organization: